Advancing the Role of Pharmacy in Tobacco Cessation

提升药房在戒烟中的作用

• 批准号: 10461930
• 负责人: KAREN S HUDMON
• 金额: $ 28.13万
• 依托单位: PURDUE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-09-18 至 2024-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10461930
• 关键词: Address; Arizona; Awareness; Bupropion; California; Centers for Disease Control and Prevention (U.S.); Colorado; Communities; Continuing Education; Counseling; Development; E-learning; Ensure; Evaluation; Excision; FDA approved; Faculty; Feedback; Funding; Future; Goals; Grant; Health; Health Expenditures; Health Personnel; Health Professional; Hour; Human Resources; Idaho; Indiana; Individual; Kentucky; Laws; Maine; Methodology; Methods; Minor; Morbidity - disease rate; New Mexico; Online Systems; Oregon; Participant; Patient Care; Patients; Persons; Pharmaceutical Preparations; Pharmacists; Pharmacotherapy; Pharmacy Schools; Pharmacy Students; Pharmacy facility; Phase; Population; Process; Program Development; Protocols documentation; Provider; Role; Schools; Series; Site; Smoke; Smoker; Speed; Statutes and Laws; Students; Surveys; Time; Tobacco; Tobacco Use Cessation; Tobacco use; Trainers Training; Training; Training Programs; United States; United States Public Health Service; Work; authority; base; care outcomes; effective therapy; evidence base; experience; innovation; meetings; member; mortality; nicotine replacement; novel strategies; program dissemination; programs; quitline; response; skills; smoking cessation; theories; tobacco user; varenicline

Although most tobacco users would like to quit, the majority do not receive professional assistance, and fewer than 5% who try to quit on their own are successful. The most effective approach for quitting combines pharmacotherapy with counseling, yet few clinicians routinely address tobacco use in practice. In recent years, only minor advancements have been made toward increasing the proportion of patients who receive professional assistance or use FDA-approved cessation medications, and novel approaches are needed to disrupt the status quo. One largely untapped yet highly accessible population of providers is pharmacists. In 2004, New Mexico implemented the first protocol granting pharmacists authority to prescribe smoking cessation medications, and eight additional states recently have signed similar legislation into law (with another 14 states in the process). While the passage of legislation is an essential first step, the second step – preparing the profession to act on these new prescriptive authorities – is equally important. The primary objective of this R25 application is to provide assistance to states attempting to advance pharmacy’s role in tobacco cessation. Through partnerships with key organizations, we will develop and disseminate training programs for all members of the pharmacy profession: pharmacists, pharmacy technicians, and pharmacist preceptors who host experiential training sites for pharmacy students. Program development and dissemination will be grounded in theory, building upon strong methodology established in our team’s prior work. More broadly, we will build bridges between the pharmacy profession, State Departments of Health, and tobacco quitlines, thereby providing patients with increased access to evidence-based methods for quitting. The specific aims of this R25 application are to: AIM 1. Develop a suite of live and enduring web-based tobacco cessation training programs for (a) pharmacy personnel, including pharmacists and technicians, and (b) pharmacist preceptors who host experiential training sites for pharmacy students. AIM 2. In a pilot Phase I (Years 01/02), conduct a series of 5 live training programs for Indiana pharmacists and launch web-based trainings for Indiana pharmacists and technicians. AIM 3. Revise materials, as appropriate, based on feedback from Phase I participants prior to a full-launch Phase II (Years 02–05), providing live and web-based trainings in states where pharmacists can prescribe smoking cessation medications. Overall, an estimated 5,680 pharmacists and 1,000 technicians will be trained. AIM 4. Apply a mixed methods evaluation approach to estimate the reach and impact of the training programs. This proposed educational initiative is both timely and needed—importantly, it capitalizes on heightened awareness due to recent legislative advances, and it builds upon our team’s decades of experience in training pharmacists, technicians, and students to assist their patients with the cessation of tobacco use.

尽管大多数吸烟者想要戒烟，但大多数人没有得到专业帮助，更少的人 超过5%的人尝试自己戒烟是成功的。停用联合收割机最有效的方法 通过咨询进行药物治疗，但很少有临床医生在实践中例行公事地解决烟草使用问题。近年来，只有 在增加接受专业治疗的患者比例方面取得了一些小的进步 帮助或使用FDA批准的戒烟药物，需要新的方法来打破现状。 药剂师是一个在很大程度上尚未开发但很容易获得的提供者群体。2004年，新墨西哥州 实施第一个议定书，授予药剂师开戒烟药物的权力，以及 最近又有8个州签署了类似的立法成为法律(另有14个州正在进行中)。 虽然通过立法是至关重要的第一步，但第二步--为职业采取行动做好准备 这些新的规范性权威--也同样重要。 这项R25申请的主要目标是为试图推进 药房在戒烟中的作用。通过与主要组织的伙伴关系，我们将制定和 为药剂业的所有成员：药剂师、药房技术员、 以及药师导师，他们为药学学生提供体验培训网站。程序开发和 传播将以理论为基础，建立在我们团队先前工作中建立的强有力的方法基础上。 更广泛地说，我们将在药剂业、州卫生部和烟草之间建立桥梁 戒烟热线，从而为患者提供了更多的循证戒烟方法。 此R25应用程序的具体目标是： 目标1.为(A)药房开发一套实时和持久的基于网络的戒烟培训计划 人员，包括药剂师和技术员，以及(B)主持体验式培训的药剂师导师 药学专业学生的培训网站。 目标2.在试点阶段第一阶段(01/02年)，为印第安纳州药剂师和 为印第安纳州的药剂师和技术人员开展基于网络的培训。 目标3.在全面发布阶段之前，根据第一阶段参与者的反馈，酌情修订材料 II(02-05年)，在药剂师可以开出吸烟处方的州提供现场和网络培训 戒烟药物。总体而言，估计将培训5680名药剂师和1000名技术员。 目的4.应用混合方法评估培训计划的覆盖范围和影响。 这一拟议的教育倡议既及时又必要--重要的是，它利用了 意识源于最近的立法进展，它建立在我们团队数十年的培训经验基础上 药剂师、技术员和学生帮助他们的病人戒烟。